| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.88B | +25.8% |
| Cost of Revenue | $4.41B | +24.3% |
| Gross Profit | $4.47B | +27.2% |
| R&D Expense | $1.37B | -21.0% |
| SG&A Expense | $410.0M | -16.5% |
| Operating Income | $1.07B | +175.8% |
| Income Tax | $209.0M | +294.3% |
| Net Income | $2.02B | +1429.5% |
| EPS (Basic) | $1.57 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.50B | +6.0% |
| Short-term Investments | $3.98B | +10.7% |
| Accounts Receivable | $342.0M | +21.3% |
| Inventory | $26.0M | +36.8% |
| Current Assets | $7.25B | +15.6% |
| Total Assets | $13.92B | +23.2% |
| Current Liabilities | $1.96B | +117.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.62B | +71.2% |
| Capital Expenditures | $19.0M | -51.3% |
| Investing Cash Flow | -$1.59B | -27.5% |
| Financing Cash Flow | $61.0M | +1.7% |
| Free Cash Flow | $1.60B | +76.5% |
| +1470.0% |
| EPS (Diluted) | $1.55 | +1450.0% |
| Stockholders' Equity |
| $11.56B |
| +27.5% |